期刊文献+

晚期糖基化终末产物的临床病理机制及抑制剂的研究进展 被引量:11

New development in clinical pathological actions and inhibitors of advanced glycation endproducts
下载PDF
导出
摘要 在糖尿病患者体内以及衰老进程中晚期糖基化终末产物 (AGEs)是不断积累的 ,其可以通过直接或间接的方式对机体产生病理作用。本文概述了AGEs对各种组织或细胞包括心血管组织、肾脏、大脑和骨组织等的间接病理作用和机制、介导该作用的AGEs受体或其他结合蛋白 。 Advanced glycation endproducts (AGEs) always accumulate in diabetic patients and senile people, which can cause pathological actions to the whole body in direct and indirect way.This article reviews the indirect pathological actions and mechanism of AGEs to various tissues and cells,including cardiovascular tissue,kidney,brain and bones,etc.,the AGEs receptor and other AGEs binding proteins that mediates this action and inhibitors that inhibit the formation and action of AGEs.
作者 王真 李电东
出处 《中国新药杂志》 CAS CSCD 北大核心 2002年第2期113-116,共4页 Chinese Journal of New Drugs
基金 国家重点基础研究发展规划资助项目 (G2 0 0 0 0 5 70 10 )
关键词 晚期糖基化终末产物 AGEs受体 氨基胍 临床病理机制 抑制剂 advanced glycation endproducts(AGEs) AGEs receptor aminoguanidine
  • 相关文献

参考文献23

  • 1[1]Biernaus A,Hofmann MA,Ziegler R,et al.AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus.I.The AGE concept[J].Cardiovasc Res,1998,(37)∶586-600.
  • 2[2]Song X,Bao MM,Li DD.Advanced glycation in D-galactose induced mouse aging mode[J].Mech Ageing Dev,1999,108∶241-253.
  • 3[3]Vlassara H,Fuh H,Donnelly T,et al.Advanced glycation endproducts promote adhension molecule-1(VCAM-1,ICAM-1)expression and atheroma formation in normal rabbits[J].Mol Med,1995,1∶447-456.
  • 4[4]Yamagishi S,Fujimori H,Yonekura H,et al.Advanced glycation endproducts accelerate calcification in microvascular pericytes[J].Biochem Biophys Res Commun,1999,258(2)∶353-357.
  • 5[5]Chih-wei Y,Vlassara H,Emmanuei P.Peten,et al.Advanced glycation endproducts up-regulate gene expression found in diabetic glomerular disease[J].Proc Natl Acad Sci,1994,91∶9436-9440.
  • 6[6]Scivittaro V,Ganz MB,Weiss MF,et al.AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells[J].Am J Physiol Renal Physiol,2000,278(4)∶F676-683.
  • 7[7]Sasaki N,Fukatsu R,Tsuzuki K,et al.Advanced glycation end products in Alzheimer's disease and other neurodegenerative disease[J].Am J Pathol,1998,153∶1149-1155.
  • 8[8]Munch G,Gerlach M,Sian J,et al.Advanced glycation end products in neurodegeneration:more than early markers of oxidative stress[J]?Ann Neurol,1998,44(3 Suppl 1)∶S85-S88.
  • 9[9]Miyata T,Kawai R,Taketomi S,et al.Possible involvement of advanced glycation end products in bone resorption[J].Nephrol Dial Transplant,1996,11(Suppl 5)∶S54-S57.
  • 10[10]Miyata T,Notoya K,Yoshida K,et al.Advanced glycation endproducts enhance osteoclast-induced bone resorption in cultured mouse unfractioned bone cells and in rats implants subcutaneously with devitalized bone particles[J].J Am Soc Nephrol,1997,8∶260-270.

同被引文献141

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部